The GAS trial: neurocognitive outcomes 5 years after infant anesthesia
The GAS trial: neurocognitive outcomes 5 years after infant anesthesia
批准号:
8942678
负责人:
David C Bellinger
金额:
$8.96万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-18 至 2018-08-31
关键词:
5 year oldAcademic achievementAccountingAdaptive BehaviorsAddressAgeAnesthesia proceduresAnestheticsAnimal ModelAttentionAustraliaBehaviorBrainCanadaChildChildhoodClinicalCohort StudiesConduction AnesthesiaConfidence IntervalsDataDevelopmentDevelopmental Delay DisordersDoseEnrollmentEtiologyEuropeExposure toFrequenciesFundingGeneral AnesthesiaGeneral anesthetic drugsGoldHumanInfantInguinal HerniaIntelligenceInternationalIsofluraneItalyLanguageLeadLearningLightMemoryMidazolamNecrosisNetherlandsNeurocognitiveNeurologic ExaminationNeuronsNew ZealandNitrous OxideNorth AmericaNursery SchoolsObservational StudyOperative Surgical ProceduresOutcomeParticipantPrimatesPropofolPublic HealthRandomizedRandomized Controlled TrialsRegression AnalysisRiskSafetyScheduleSedation procedureSideSiteSocial PerceptionTestingToddlerUnited KingdomVision ScreeningVisuospatialawakeclinical research sitedesignexecutive functionfollow-uphearing screeninginfancyinguinal herniorrhaphyneonateneurodevelopmentneuron lossneurotoxicneurotoxicitypatient populationprospectivepublic health relevancerandomized trialrepairedresearch studysedativesevofluraneskillstrial comparingvisual motor
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Each year millions of infants and toddlers undergo surgery that involves exposure to general anesthesia. Whether such exposure increases a child's neurodevelopmental risk has never been established. Studies in animal models provide compelling evidence that commonly used agents (e.g., sevoflurane, isoflurane, propofol, midazolam, nitrous oxide) enhance neuronal cell death in the immature brain, in some studies at doses lower than those required to achieve a surgical plane of anesthesia. Some retrospective cohort studies in children have shown that early exposure to general anesthesia, even a single short exposure, is associated with later learning difficulties. The clinical implications of these data are controversial, however, because none of the studies used the gold standard design of a randomized trial to evaluate neurodevelopment in children after exposure to anesthetic agents in infancy, thus limiting the inferences that can be drawn about causality. This application seeks funding for USA sites to complete the GAS study, an ongoing international, prospective, multi-site, randomized, controlled, equivalence trial comparing children's neurodevelopment following receipt of general or regional awake anesthesia. A total of 149 infants who underwent inguinal herniorrhaphy, a common surgery that can be performed using either form of anesthesia, were enrolled at 10 sites in the USA. An additional 573 infants were enrolled at sites in Australia/New Zealand, the United Kingdom, Canada, Italy and the Netherlands, for a total enrollment of 722. Enrollment was completed in January 2013. The primary hypothesis is that neurodevelopmental outcomes at 5 years of age are equivalent in children who received general anesthesia or regional awake anesthesia. The primary endpoint is the Full Scale IQ on the Wechsler Preschool and Primary Scale of Intelligence. Secondary endpoints include test scores that assess specific domains, including attention/executive function, verbal/language skills, memory and learning, social perception, visuomotor integration, sensorimotor skills, academic achievement, behavior, and adaptive skills. The primary hypothesis of equivalence in Full Scale IQ at 5-years of age will be accepted if the 2-sided 95% confidence interval of the adjusted treatment group difference in means lies within -5 and +5 points. In light of the widespread use of general anesthesia in infant surgery, the results will have substantial public health implications, either supporting the safety of general anesthesia or indicating the need to consider alternative sedation strategies in this patient population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The GAS trial: neurocognitive outcomes 5 years after infant anesthesia
-
批准号:9146375
-
项目类别:
-
资助金额:$21.84万
-
财政年份:2015
-
负责人:David C Bellinger
-
依托单位:
Effects of general vs. regional anesthesia on infant neurodevelopment and apnea
-
批准号:8484856
-
项目类别:
-
资助金额:$44.85万
-
财政年份:2010
-
负责人:David C Bellinger
-
依托单位:
Effects of general vs. regional anesthesia on infant neurodevelopment and apnea
-
批准号:7937630
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2010
-
负责人:David C Bellinger
-
依托单位:
Effects of general vs. regional anesthesia on infant neurodevelopment and apnea
-
批准号:8145555
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2010
-
负责人:David C Bellinger
-
依托单位:
Superfund Metal Mixtures, Biomarkers and Neurodevelopment
-
批准号:8451454
-
项目类别:
-
资助金额:$232.64万
-
财政年份:2010
-
负责人:David C Bellinger
-
依托单位:
Effects of general vs. regional anesthesia on infant neurodevelopment and apnea
-
批准号:8305085
-
项目类别:
-
资助金额:$50.74万
-
财政年份:2010
-
负责人:David C Bellinger
-
依托单位:
Superfund Metal Mixtures, Biomarkers and Neurodevelopment
-
批准号:8254509
-
项目类别:
-
资助金额:$243.6万
-
财政年份:2010
-
负责人:David C Bellinger
-
依托单位:
Metal Exposure and Children?s Preschool Neurodevelopment
-
批准号:7909657
-
项目类别:
-
资助金额:$41.29万
-
财政年份:2009
-
负责人:David C Bellinger
-
依托单位:
Metal Exposure and Children?s Preschool Neurodevelopment
-
批准号:8249122
-
项目类别:
-
资助金额:$44.04万
-
财政年份:2008
-
负责人:David C Bellinger
-
依托单位:
Metal Exposure and Children?s Preschool Neurodevelopment
-
批准号:7628141
-
项目类别:
-
资助金额:$49.72万
-
财政年份:2008
-
负责人:David C Bellinger
-
依托单位:
Metal Exposure and Children?s Preschool Neurodevelopment
-
批准号:8046487
-
项目类别:
-
资助金额:$46.07万
-
财政年份:2008
-
负责人:David C Bellinger
-
依托单位:
Metal Exposure and Children?s Preschool Neurodevelopment
-
批准号:7350056
-
项目类别:
-
资助金额:$57.71万
-
财政年份:2008
-
负责人:David C Bellinger
-
依托单位:
Interdisciplinary Training: Neurodevelopmental Toxi(RMI)
-
批准号:6953182
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2004
-
负责人:David C Bellinger
-
依托单位:
Interdisciplinary Training: Neurodevelopmental Toxicology
-
批准号:7115694
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2004
-
负责人:David C Bellinger
-
依托单位:
Interdisciplinary Training: Neurodevelopmental Toxicology(RMI)
-
批准号:7487992
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2004
-
负责人:David C Bellinger
-
依托单位:
Training: Neurodevelopmental Toxicology (RMI)
-
批准号:6874216
-
项目类别:
-
资助金额:$13.33万
-
财政年份:2004
-
负责人:David C Bellinger
-
依托单位:
Interdisciplinary Training: Neurodevelopmental Toxicology(RMI)
-
批准号:7284270
-
项目类别:
-
资助金额:$25.64万
-
财政年份:2004
-
负责人:David C Bellinger
-
依托单位:
NEUROBEHAVIORAL SEQUELAE OF CARDIAC SURGERY
-
批准号:6499095
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2001
-
负责人:David C Bellinger
-
依托单位:
HEALTH & WELL BEING STUDY OF PRETERM NEWBORNS: FOLLOW UP PHASE
-
批准号:6568549
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2001
-
负责人:David C Bellinger
-
依托单位:
NEUROBEHAVIORAL SEQUELAE OF CARDIAC SURGERY
-
批准号:6844626
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2001
-
负责人:David C Bellinger
-
依托单位:
海外基金